Phase II study of weekly irinotecan (CPT-11) as second-line treatment of patients with advanced colorectal cancer.

J Cassinello; P López-Alvarez; A Martínez-Guisado; M Valladares; G Huidobro; R López; U Bohn; I Sevilla; P Ballesteros; M Jorge

doi:10.1385/MO:20:1:37

Phase II study of weekly irinotecan (CPT-11) as second-line treatment of patients with advanced colorectal cancer.

Identifier:nobleid.org/w1/20260515/18BE59AB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/18BE59AB.svg?ark=w1%2F20260515%2F18BE59AB)](https://nobleid.org/work/w1/20260515/18BE59AB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase II study of weekly irinotecan (CPT-11) as second-line treatment of patients with advanced colorectal cancer.

Identifier:nobleid.org/w1/20260515/18BE59AB

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/18BE59AB.svg?ark=w1%2F20260515%2F18BE59AB)](https://nobleid.org/work/w1/20260515/18BE59AB)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work